Compound Summary
Compound Information
ellipticine
Compound Name: | ellipticine |
Compound CID: | 3213 |
Synonyms: | ellipticine 519-23-3 5,11-Dimethyl-6H-pyrido4,3-bcarbazole Elliptisine NSC 71795 More... |
Iupac Name: | 5,11-dimethyl-6H-pyrido[4,3-b]carbazole |
InChI: | InChI=1S/C17H14N2/c1-10-14-9-18-8-7-12(14)11(2)17-16(10)13-5-3-4-6-15(13)19-17/h3-9,19H,1-2H3 |
InChIKey: | CTSPAMFJBXKSOY-UHFFFAOYSA-N |
Canonical Smiles: | CC1=C2C=CN=CC2=C(C3=C1NC4=CC=CC=C43)C |
Isomeric Smiles: | CC1=C2C=CN=CC2=C(C3=C1NC4=CC=CC=C43)C |
Molecular Weight: | 246.31 |
Molecular Formula: | C17H14N2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
ellipticine
Molecular Weight: | 246.31 |
Molecular Formula: | C17H14N2 |
Hydrogen Bond Donor Count: | 1 |
Hydrogen Bond Acceptor Count: | 1 |
Rotatable Bond Count: | 0 |
Heavy Atom Count: | 19 |
Complexity: | 342 |
Synonyms
ellipticine
| ellipticine | ellipticine |
|---|---|
ellipticine |
519-23-3 |
5,11-Dimethyl-6H-pyrido4,3-bcarbazole |
Elliptisine |
NSC 71795 |
TCMDC-125546 |
5,11-Dimethyl-6H-pyrido(4,3-b)carbazole |
NSC-71795 |
ICIG 770 |
5,11-Dimethylpyrido4,3-bcarbazole |
UNII-117VLW7484 |
NSC71795 |
CHEMBL123 |
MLS000028487 |
MLS000736786 |
CHEBI:4776 |
6H-Pyrido(4,3-b)carbazole, 5,11-dimethyl- |
6H-Pyrido4,3-bcarbazole, 5,11-dimethyl- |
CCG-36483 |
117VLW7484 |
SMR000058370 |
CCRIS 2003 |
CP 5 |
SR-01000003083 |
EINECS 208-264-0 |
BRN 0221300 |
elliptecine |
Ellipticin |
ellipticine, HCl |
5,3-bcarbazole |
Prestwick_194 |
Ellipticine, synthetic |
Opera_ID_1748 |
Prestwick0_000614 |
Prestwick1_000614 |
Prestwick2_000614 |
Prestwick3_000614 |
Lopac-E-3380 |
6H-Pyrido4,3-bcarbazole,5,11-dimethyl- |
Probes1_000152 |
Probes2_000130 |
cid_3213 |
Neuro_000031 |
Lopac0_000531 |
REGID_for_CID_3213 |
BSPBio_000548 |
5-23-09-00417 (Beilstein Handbook Reference) |
MLS001076505 |
SCHEMBL138079 |
SPBio_002767 |
BPBio1_000604 |
AOB6851 |
DTXSID30199855 |
HMS1569L10 |
HMS2096L10 |
HMS2230H10 |
HMS3261L03 |
HMS3371L09 |
BCP13208 |
EX-A2053 |
ZINC1846592 |
Tox21_500531 |
BDBM50004233 |
MFCD00010524 |
AKOS024457578 |
CS-5294 |
LP00531 |
SDCCGSBI-0050514.P002 |
VZ29809 |
CCG36483; NSC71795 |
NCGC00015411-01 |
NCGC00015411-02 |
NCGC00015411-03 |
NCGC00015411-04 |
NCGC00015411-05 |
NCGC00015411-06 |
NCGC00015411-07 |
NCGC00015411-08 |
NCGC00015411-09 |
NCGC00015411-10 |
NCGC00015411-12 |
NCGC00015411-19 |
NCGC00022199-03 |
NCGC00022199-04 |
NCGC00022199-05 |
NCGC00261216-01 |
AS-77042 |
CAS-519-23-3 |
HY-15753 |
NCI60_040685 |
5,11-dimethyl-2H-pyrido4,3-bcarbazole |
DB-052047 |
WLN: T D6 B656 FN LMJ C1 J1 |
B7382 |
EU-0100531 |
FT-0632272 |
C09154 |
E 3380 |
K00071 |
SR-01000003083-2 |
SR-01000003083-6 |
BRD-K85985071-001-03-3 |
BRD-K85985071-001-16-5 |
BRD-K85985071-001-22-3 |
Q10359556 |
Experimental Data
ellipticine
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | 8 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
ellipticine
Statistics Data
ellipticine
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 8 | 1 | 1 |
Statistics Data Visualization
ellipticine
